ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.32
−1.12%Margins
Gross margin
60.4%
EBITDA margin
-0.3%
EBIT margin
9.6%
Net margin
-36.5%
FCF margin
-61.0%
93.8%
Return on equity
-11.3%
Return on assets
3.8%
Return on invested capital
0.33x
Asset turnover
-$198.7M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026